Atlas Trials

Huai'an First People's Hospital

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Huai'an First People's Hospital

RecordFirmDate
A Single-center, Single-arm, Phase II Clinical Study of Iparomlimab and Tuvonralimab Injection Combined With Regorafenib in the Treatment of Advanced Second-line or Above Hepatocellular Carcinoma (NCT07115550)Huai'an First People's Hospital2025-08-26
A Prospective, Single Arm, Open Label, Phase II Clinical Study on the Efficacy and Safety of Ivonescimab (AK112) Combined With TAS-102 in the Treatment of Refractory MSS/pMMR Advanced Colorectal Cancer (NCT06936488)Huai'an First People's Hospital2025-03-01
Oxygen Study-Orelabrutinib Combined With Obinutuzumab(O2) for First-Line Treatment of Marginal Zone Lymphoma (NCT06566807)Huai'an First People's Hospital2024-08-25
A Clinical Study Evaluating the Safety and Efficacy of ZRMT Regimen in the Treatment of PCNSL (NCT06445257)Huai'an First People's Hospital2023-09-15
Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA. (NCT06328179)Huai'an First People's Hospital2022-05-24
Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus (NCT03585530)Huai'an First People's Hospital2018-09-05
Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma (NCT03600831)Huai'an First People's Hospital2018-08-20

Track Huai'an First People's Hospital automatically

Every clearance here is in the API, with alerts when new ones post.